Home' Australian Pharmacist : Australian Pharmacist January 2015 Contents Australian Pharmacist January 2015 I ©Pharmaceutical Society of Australia Ltd.
CONTINUING PROFESSIONAL DEVELOPMENT
COUNSELLING IN PRACTICE
Australian Obesity Guidelines.
The Australian Dietary Guidelines ‘use
the best available scientific evidence
to provide information on the types
and amounts of foods, food groups
and dietary patterns that aim to:
promote health and wellbeing, reduce
the risk of diet-related conditions and
reduce the risk of chronic disease’.
The National Institute for Health and
Care Excellence guideline Managing
overweight and Obesity in adults –
lifestyle management services. At:
NHMRC also recommends additional
tools and resources in overweight
and obesity. At: www.nhmrc.gov.au/
Alexis wants to lose weight
Alexis thanks you for your time and
decides to trial some changes to her
diet that you have recommended
before starting any medicines to aid her
weight loss. She is also planning to start
exercising more regularly by going for
a brisk walk with her sister for at least
30 minutes each weekday, as well as an
aqua aerobics class on a Sunday morning.
Alexis has recorded her weight and BMI
in her diary today and is hoping to keep
a record of this each week to monitor her
progress. She will be back to see you in
two months to review her progress and
decide whether she needs the medicines
you have discussed with her today.
Weight loss is a common reason to seek
advice and studies show weight loss as
little as 5–10% can have considerable
health benefits. Pharmacists are
well placed to help with weight and
general health risk assessment and
recommended appropriate lifestyle
and pharmacological treatment where
A combination of diet, exercise and
behavioural modification is the starting
point for optimal weight management
and drug therapy should always be part
of a program that emphasises these
1. Whitlock G Lewington S, Sherliker P, et al. Body-mass index
and cause-specific mortality in 900,000 adults: collaborative
analyses of 57 prospective studies. Lancet. 2009;373(1083).
2. Cardiovascular Expert Group. Therapeutic Guidelines:
Cardiovascular. Melbourne: Therapeutic Guidelines; 2012.
3. NPS MedicineWise. Cardiovascular Risk Calculators.
2014. At: www.nps.org.au/conditions/heart-blood-and-
4. Jensen MD, Apovian CM, et al. Guideline for the
management of overweight and obesity in adults: A
report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines and
The Obesity Society. J Am Coll Cardiol 2014;63:2985-3023.
5. World Health Organization. Obesity: preventing and
managing the global epidemic. Report of a WHO
consultation. 2000. At: www.who.int/nutrition/
6. Rossi S, ed. Australian medicines handbook. Adelaide:
Australian Medicines Handbook; 2013. At: www.amh.net.
7. Queensland Health. Nutrition Education Materials Online
(NEMO). Using Body Mass Index. 2014. At: www.health.qld.
8. National Health and Medical Research Council. Clinical
practice guidelines for the management of overweight
and obesity in adults, adolescents and children in
Australia. 2013. At: https://www.nhmrc.gov.au/guidelines/
9. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist
circumferences, and health risk: evidence in support of
current National Institutues of Health Guidelines. Arch
Intern Med 2002;162:2074–9 .
10. WebMD. hCG for Weight Loss 2014. At: www.webmd.com/
11. National Health and Medical Research Council. Australian
Dietary Guidelines. 2013. At: https://www.nhmrc.gov.au/
12. Department of Health. Australia’s physical activity and
sedentary behaviour guidelines: evidence summary.
2014. At: www.health.gov.au/internet/main/publishing.
13. British Medical Journal Best Practice. Obesity in Adults. 2014.
14. Barlow SE, Dietz WH. Obesity evaluation and treatment:
expert committee recommendations. The Maternal
and Child Health Bureau, Health Resources and Services
Administration and the Department of Health and Human
Services. Paediatrics 1998;102:29.
1. Weight loss as little as 5–10% may
have considerable health benefits,
a) Improved control of asthma and chronic
obstructive pulmonary disease (COPD).
b) Elevation in blood pressure.
c) Improved control of dyslipidaemia.
d) Reduction in HbA1c of 3%.
2. A customer tells you that his height
is 180 cm and his weight is 106 kg.
What is his body mass index (BMI)?
a) 27 kg/m2
b) 29 kg/m2
c) 31 kg/m2
d) 33 kg/m2
3. Which of the following regarding
orlistat therapy is CORRECT?
a) Evidence suggests individuals taking
orlistat will lose on average 3 kg more
weight at 1 month than those receiving
b) Orlistat therapy will reduce
haemoglobin A1c (HbA1c)
concentrations consistent with the
weight loss achieved.
c) Use of orlistat therapy for greater than
12 weeks is not recommended without
a 4–12 week drug-free period.
d) Orlistat works by reducing the
absorption of approximately 20% of fat-
4. Which of the following regarding
exercise in weight management is
a) Drug therapy with orlistat or
phentermine should always be part of a
program that includes physical activity.
b) Any increase in physical activity is
beneficial to overall health, even if there
is minimal or no weight loss.
c) The goal should be to reduce
movement and build a more sedentary
d) The recommended amount of exercise
in a person who is overweight or
obese is approximately 300 minutes
of moderate-intensity activity, or
150 minutes of vigorous activity, or an
equivalent combination of moderate-
intensity and vigorous activities each
5. Which of the following is NOT a
b) Peptic ulcer disease.
Links Archive Australian Pharmacist December 2014 Australian Pharmacist February 2015 Navigation Previous Page Next Page